Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Receives Average Rating of "Buy" from Analysts

Retrieved on: 2021-02-11 13:52:49

Tags for this article:

Click the tags to see associated articles and topics

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Receives Average Rating of "Buy" from Analysts. View article details on hiswai:

Excerpt

Schonfeld Strategic Advisors LLC purchased a new position in shares of Zynerba Pharmaceuticals during the 3rd quarter valued at approximately ...

Article found on: www.marketbeat.com